Menu

Filtros : "SHINJO, SAMUEL KATSUYUKI" "World journal of clinical cases" Removido: "ATROFIA MUSCULAR" Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Artigo de periodico

    Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us? (2022)

    Goncalves Junior, Jucier; Shinjo, Samuel Katsuyuki

    Source: World journal of clinical cases. Unidade: FM

    Subjects: HIV, MIOPATIAS CONGÊNITAS ESTRUTURAIS, REUMATOLOGIA, TERAPÊUTICA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      GONCALVES JUNIOR, Jucier e SHINJO, Samuel Katsuyuki. Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?. World journal of clinical cases, v. 10, n. 4, p. 1454-1456, 2022Tradução . . Disponível em: https://doi.org/10.12998/wjcc.v10.i4.1454. Acesso em: 15 out. 2024.

    • APA

      Goncalves Junior, J., & Shinjo, S. K. (2022). Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us? World journal of clinical cases, 10( 4), 1454-1456. doi:10.12998/wjcc.v10.i4.1454

    • NLM

      Goncalves Junior J, Shinjo SK. Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us? [Internet]. World journal of clinical cases. 2022 ; 10( 4): 1454-1456.[citado 2024 out. 15 ] Available from: https://doi.org/10.12998/wjcc.v10.i4.1454

    • Vancouver

      Goncalves Junior J, Shinjo SK. Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us? [Internet]. World journal of clinical cases. 2022 ; 10( 4): 1454-1456.[citado 2024 out. 15 ] Available from: https://doi.org/10.12998/wjcc.v10.i4.1454

  • Artigo de periodico

    Reflections on the prevalence of human leukocyte antigen-B27 and human leukocyte antigen-B51 co-occurrence in patients with spondylarthritis (2022)

    Goncalves, Jucier ; Sampaio-barros, Percival Degrava ; Shinjo, Samuel Katsuyuki

    Source: World journal of clinical cases. Unidade: FM

    Subjects: ESPONDILITE ANQUILOSANTE, ANTÍGENOS, MANIFESTAÇÕES CUTÂNEAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      GONCALVES, Jucier e SAMPAIO-BARROS, Percival Degrava e SHINJO, Samuel Katsuyuki. Reflections on the prevalence of human leukocyte antigen-B27 and human leukocyte antigen-B51 co-occurrence in patients with spondylarthritis. World journal of clinical cases, v. 10, n. 23, p. 8422-8424, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50409. Acesso em: 15 out. 2024.

    • APA

      Goncalves, J., Sampaio-barros, P. D., & Shinjo, S. K. (2022). Reflections on the prevalence of human leukocyte antigen-B27 and human leukocyte antigen-B51 co-occurrence in patients with spondylarthritis. World journal of clinical cases, 10( 23), 8422-8424. doi:10.12998/wjcc.v10.i23.8422

    • NLM

      Goncalves J, Sampaio-barros PD, Shinjo SK. Reflections on the prevalence of human leukocyte antigen-B27 and human leukocyte antigen-B51 co-occurrence in patients with spondylarthritis [Internet]. World journal of clinical cases. 2022 ; 10( 23): 8422-8424.[citado 2024 out. 15 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50409

    • Vancouver

      Goncalves J, Sampaio-barros PD, Shinjo SK. Reflections on the prevalence of human leukocyte antigen-B27 and human leukocyte antigen-B51 co-occurrence in patients with spondylarthritis [Internet]. World journal of clinical cases. 2022 ; 10( 23): 8422-8424.[citado 2024 out. 15 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50409
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024